The effect of hypoxia (reduction of arterial Po 2 to 26-28 mm Hg) on cerebral blood flow (CBF) and cerebral oxygen consumption (CMRO 2 ) was studied in paralyzed and artificially ventilated rats, using a CBF technique of improved accuracy at high flow rates. Results obtained on animals maintained on 70% N 2 O unexpectedly showed that hypoxia of this severity is accompanied by an increase in CMRO 2 , and they indicated that 2 different mechanisms are involved, both related to catecholamine metabolism. In one breed of Wistar rats studied, hypoxia was accompanied by a 6-fold increase in CBF and by an increase in CMRO 2 to 180% of control. Prior removal of the adrenal glands curtailed the increase in CBF (400% of control) and CMRO 2 (125% of control). The excessive increase in CMRO 2 (to 180% of control) did not occur in another breed of Wistar rats. However, since infusion of adrenaline in normoxic animals gave rise to a doubling of CMRO2 it is concluded that, at least under some circumstances, circulating catecholamines can increase oxygen consumption in the hypoxic brain. In the second breed of rats studied, hypoxia was consistently accompanied by a 20-30% increase in CMRO 2 which was unaffected by prior adrenalectomy. Since the increase was prevented by sedative and anesthetic doses of diazepam, it is tentatively concluded that the increase was elicited by increased activity in cerebral catecholaminergic pathways. The conclusion is supported by parallel studies showing that a similar increase in CMR0 2 occurs in hypercapnia, which is blocked both by diazepam and propranolol.
RECENT RESULTS from this laboratory showed that when the nitrous oxide supply was withdrawn from paralyzed and artificially ventilated rats there was a pronounced increase in cerebral metabolic rate for oxygen (CMRO 2 ) and cerebral blood flow (CBF), which could be blocked by previous adrenalectomy, or by administration of propranolol. 1 It was tentatively concluded that the increase in CMRO 2 (and CBF) was a response to immobilization stress, mediated by circulating catecholamines.
In the course of a study of cerebral metabolic responses to hypoxia (reduction of arterial Po 2 to 25-30 mm Hg) we unexpectedly found that CMRO 2 rose. Assuming that circulatory catecholamines were responsible, we undertook an extensive study of the effects of hypoxia on CBF and CMRO 2 in nonadrenalectomized and adrenalectomized rats, using a CBF method of sufficient accuracy to resolve differences in CBF even at high flow rates. It will be shown that in one breed of rats studied, reduction of Po 2 was accompanied by an increase in CMRO 2 to almost 200 percent of control, most of which was prevented by prior removal of the adrenal glands. However, in another breed of hypoxic rats maintained on 70% N 2 O, whether adrenalectomized or not, there was a 20-30% increase in CMRO 2 . This increase was prevented by administration of diazepam. It is tentatively concluded that, during hypoxia, cerebral metabolic rate may be increased by catecholaminergic mechanisms.
Methods
All experiments were performed on male S.P.F. Wistar rats (290-375 g). During the course of the study, the supplier (M^llegaard, Copenhagen) started breeding a new colony of Wistar rats. Since the results obtained on these breeds differed, they will be described separately. Rats from the original breed constitute series A, from the second, series B and C. delivering 70% N 2 O and 30% O 2 . Both femoral arteries were cannulated for blood pressure recording and anaerobic sampling of blood, and one femoral vein for slow infusion of donor blood during CBF measurement. In one group, the adrenal glands were removed by a dorsal approach. The posterior part of the superior sagittal sinus was exposed by a small burr hole for sampling of cerebral venous blood. Body temperature was maintained close to 37°C, and ventilation was adjusted to give an arterial Pco 2 of 35-40 mm Hg.
Series B. Procedures were similar to those in series A except that in 3 of 4 groups 0.7-0.8% halothane was delivered during the operative procedures. When these were completed, halothane supply was discontinued and the animals were ventilated on 70% N 2 O. In one group, the adrenal glands were removed. In another, the animals were sham-operated (with gentle handling of the adrenal glands).
Series C. Initial anesthetic and operative procedures were the same as in series A. Following completion of operative procedures, rats were either infused with 2.25 mg'kg 1 of diazepam during 1 min, followed by a constant infusion of 5 mg'kg^hr 1 , or with 7.5 mg'kg" 1 , followed by 15 mg^kg^hr 1 . At the end of the initial infusion period (1 min) the nitrous oxide supply was discontinued and the animals were ventilated with 30% O 2 and 70% N 2 .
Induction of Hypoxia
Irrespective of the previous handling of the animals and the anesthesia used, the animals were allowed a 15-20 min steady state period before hypoxia was induced. In all animals, the inspired oxygen concentration was then lowered to give an arterial Po 2 of 26-28 mm Hg. In animals maintained on 70% N 2 O, oxygen was replaced by nitrogen gas to maintain N 2 O concentration constant. In animals given diazepam, O 2 was replaced by N 2 . In all animals, a small amount of carbon dioxide was added to the insufflated gas mixture at the time of induction of hypoxia to prevent a marked fall in arterial Pco 2 . In each animal included, Pao 2 remained constant between 25 and 30 mm Hg during the last 25 of the 30 min hypoxic period.
Measurement of CBF and CMR0 2
Cerebral (cortical) blood flow and oxygen consumption were estimated by a modification of the Kety and Schmidt technique, 2 using 133 Xenon and measurements of arterial and cerebral venous activities during the desaturation phase. 3 In each animal, the saturation period was 15-20 min. In order to allow more accurate determinations at the high flow rates encountered in hypoxia, the procedures were slightly modified. Previously, 3 -4 a 5 sec period was allowed to pass, following discontinuation of 133 Xenon supply, before the first arterial and cerebral venous samples were collected. Presently, this 5 sec lag was omitted and, following the disconnection of the 133 Xenoncontaining bag from the respirator, 2 operators sampled arterial and cerebral venous blood in rapid succession while a third recorded the time of each sample. In this way, the arterial and cerebral venous desaturation curves could be accurately resolved (see below).
As previously, CBF was calculated by the trapezoid rule, using a 133 Xenon partition coefficient of 0.83. CMRO 2 was calculated by multiplying CBF with the arteriovenous difference in oxygen content (AVDO 2 ). The latter was determined at least twice. If AVDO 2 differed by more than 10% between two consecutive samples, the experiment was discarded.
Analytical Techniques
Arterial Po 2 , Pco 2 and pH were measured using microelectrodes, with due correction for any deviation in body temperature from 37 C C. Blood oxygen content (Co 2 ) was measured in 25 /*1 samples using a polarographic technique. 5 133 Xenon was measured as previously described. 4 
Statistics
Since only one CBF measurement was performed in each animal, statistical differences between control and hypoxic rats were calculated using the unpaired Student's r-test.
Results
As figure 1 shows, the modifications allowed accurate assessment of the arterial and cerebral venous desaturation curves even when CBF exceeded 5 ml«g" 1 «min" 1 . With the new procedure, control values for CBF (and CMRO 2 ) were slightly lower than those previously published. 7 In 9 control experiments CBF was calculated both with the new procedure and with that previously used. In the latter calculation, samples drawn during the first 5 sec of desaturation were disregarded. With the present procedure, calculated CBF was 1.12 ± 0.13 and with that previously used 1.20 ± 0.15 ml'g^min 1 (means ± SEM). The results indicate that our previous procedure for calculating CBF slightly overestimates CBF (the mean difference was 6% with a SEM of 1%), probably because the area between the arterial and cerebral venous curves during the initial desaturation curve is not accurately defined unless the 5 sec lag is omitted.
Results obtained in control and hypoxic groups are given in tables 1 and 2. Animals in series A and B were maintained on 70% N 2 O, while those belonging to series C were given sedative or anesthetic doses of diazepam. 8 Series A and B differ in that animals of series A were obtained from the original breed of Wistar rats, those of series B from the new breed. Of the nitrous oxide controls, 6 of 15 were studied before the CBF technique was modified and the values were therefore corrected, using the 6% figure described above. The results obtained on hypoxic, diazepaminjected animals were compared to previous control material, 8 corrected for a 6% overestimation of CBF. In all animals exposed to hypoxia of 30 min duration, arterial oxygen content was reduced to about 25% of control. After 5 min of hypoxia the reduction was somewhat less pronounced, probably reflecting the absence of a marked fall in plasma pH (cf. table 1). In all groups, AVDO 2 was markedly reduced.
The hypoxic groups of series A were studied consecutively. When animals were rendered hypoxic for 30 min CBF increased 6-fold and there was an unexpected increase in CMRO 2 to 180% of control. Prior removal of the adrenal glands considerably curtailed, but did not completely prevent, the increase in CMRO 2 . Additional experiments snowed that, in nonadrenalectomized animals, the excessive increase in CMROj occurred after 5 min of hypoxia.
When the experiments were repeated on animals of the new breed (Series B), CMRO 2 only increased to about 125% of control. In order to study whether or not this increase was due to circulating catecholamines, 2 more groups were included, 1 in which animals were adrenalectomized and another in which a sham operation was performed. In both groups, 0.7-0.8% halothane was given during the operative procedures to minimize pain and pressor effects. The results confirmed that hypoxia is accompanied by a 20-30% increase in CMRO 2 and showed that this increase was not prevented by prior removal of the adrenal glands.
The results obtained indicated that circulating catecholamines could have been responsible for the ex- cessive increase in CMRO 2 observed in series A but that the moderate increase observed in series B was due to other factors. Since it could be suspected that an increased activity of intrinsic catecholaminergic pathways was responsible, attempts were made to pretreat animals with a /3-adrenoceptor blocker (propranolol). This invariably failed since reduction of arterial Po 2 , following administration of propranolol, resulted in cardiovascular failure. Animals were therefore pretreated with diazepam, a drug that has been assumed to block a stress-induced increase in cerebral noradrenergic neurons (see Discussion). As the results show (series C), diazepam completely prevented the increase in CMRO 2 during hypoxia. Furthermore, although CBF increased about 4-fold, the absolute CBF values were less than those observed in nitrous oxide-anesthetized animals.
Discussion
Current information suggests that although a reduction in arterial Po 2 to below 50 mm Hg leads to an increase in CBF, there is no change in CMRO 2 unless Po 2 falls to excessively low values. This information is partly based on studies in man, in whom the Pao 2 was reduced to 35-40 mm Hg, either at decreased or normal CO 2 tensions. 911 Similar results have been reported for dogs. 12 In the rat, more severe degrees of hypoxia have been studied. 13 The results showed that reduction of Pao 2 to 25 mm Hg, or lower (leading to a fall in arterial oxygen content to less than 25% of control), induced a 4-to 5-fold increase in CBF at an unchanged CMRO 2 .
Since the present results demonstrate that CMRO 2 may in fact increase during hypoxia they differ from those previously reported. A direct comparison to results obtained in man is difficult since these pertain to less severe degrees of hypoxia. For example, in the study of Cohen et al., 10 Cao 2 was reduced to about 70% of control, and no plasma acidosis developed. This may be of crucial importance since acidosis is known to release catecholamines from the adrenal glands.
14 ' 15 Probably, failure to observe an increase in CMRO 2 in our previous study on rats 13 was due to difficulties of accurately resolving arterial and cerebral venous 133 Xenon desaturation curves at the high flow rates encountered in hypoxia.
In order to facilitate discussion of the present results, values for CMRO 2 and CBF in series A, B and C will be considered together with recent data obtained in normoxic animals infused with adrenaline. The results indicate that, at least under some circumstances (series A), CMRO 2 may increase substantially by mechanisms that are related to circulating catecholamines. Although direct proof is lacking, several findings provide circumstantial evidence. First, the increase in CMRO 2 was curtailed by prior removal of the adrenal glands. Second, it is now known that if catecholamines can penetrate the blood-brain barrier they provoke increases in C M R 0 2 and CBF.
16> " Third, recent experiments have shown that i.v. infusion of adrenaline in a dose of 8 ng • kg" 1 • min 1 is accompanied by a doubling of CMR0 2 in rats obtained from the same breed as those constituting series B. 18 Clearly, the effects of adrenaline infusion on CMRO 2 is sufficiently pronounced to explain the excessive rise in CMRO 2 during hypoxia. However, some of the increase in CMRO 2 during hypoxia must have been due to other mechanisms since it persisted following removal of the adrenal glands.
On the basis of the results quoted we tentatively conclude that the excessive increase in CMRO 2 in series A was due to circulatory catecholamines. Obviously, animals of the new breed (series B) could have reacted differently either because less catecholamines were released or because penetration of amines across the blood-brain barrier was different. The results indicate that another mechanism must have been responsible for increasing CMRO 2 by 20-30% in rats belonging to series B (and in the adrenalectomized animals of series A).
In view of the fact that a variety of stressful situations are associated with signs of an increased activity of cerebral catecholaminergic neurons 19 " 22 and that benzodiazepines can block the increase in noradrenaline turnover 2325 the animals of series C were given either sedative or anesthetic doses of diazepam before hypoxia was induced. The results show that CMRO 2 did not increase in diazepam-injected animals. These results indicate that the rise of CMR0 2 in nitrous oxide-anesthetized animals is associated with increased activity in cerebral catecholaminergic neurons. At first sight, this conclusion is at variance with results showing that hypoxia leads to a reduction in the hydroxylation of tyrosine, the rate-limiting step in catecholamine synthesis. 26 However, later results have shown that such a reduction does not occur in paralysed and artificially ventilated animals, possibly due to a stress-induced change in the K m value for oxygen of tyrosine hydroxylase. 27 In view of the complex effects of diazepam, the results may not provide strong evidence that increased activity in cerebral catecholaminergic neurons was responsible for the 20-30% rise in CMRO 2 . However, results obtained in hypercapnia provide strong indirect evidence. Thus, when Paco 2 is elevated to about 80 mm Hg CMRO 2 is increased by 20-30%. This increase persists following removal of the adrenal glands, and following reduction in cerebral venous Po 2 to normal values, but is prevented by pretreatment of animals with either propranolol or diazepam. 28 Furthermore, it has been shown that even at normal tissue-Po 2 values, hypercapnia is accompanied by increased hydroxylation of tyrosine. 29 These results indicate that the mechanisms mediating an increase in CMRO 2 may be similar in hypoxia and hypercapnia, possibly involving an effect of tissue acidosis on noradrenaline turnover.
